Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02218190 · ClinicalTrials.gov registry record · NA
Alvimopan and Ileus in PSF
A NA study of Spinal Fusion and Ileus, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT02218190: Completed NA study of Spinal Fusion and Ileus, sponsored by Washington University School of Medicine.
NCT02218190 is a NA study of Spinal Fusion and Ileus that has completed, run by Washington University School of Medicine. The registered enrollment target is 31 participants, below the 482-participant average among 19 other Spinal Fusion trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02218190, a NA study of Spinal Fusion and Ileus, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine with Alvimopan reduces the incidence of post operative ileus in patients who undergo posterior spinal fusion.
Primary Outcome
To determine the effect of alvimopan on the recovery of bowel function as determined by time to first bowel movement in patients undergoing posterior spinal fusion. The effect size calculated may guide a larger, multicenter randomized controlled study. Time was measured from wound closure to bowel movement.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Alvimopan
Study Locations (1)
Missouri
- Barnes Jewish Hospital / Washington University in St. Louis School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-01 |
| Phase | NA |
What the finished NCT02218190 record still lists
NCT02218190 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 482-participant average among 19 other Spinal Fusion trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02218190 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02218190 about?
NCT02218190 is a clinical study titled "Alvimopan and Ileus in PSF". The purpose of the study is to determine with Alvimopan reduces the incidence of post operative ileus in patients who undergo posterior spinal fusion.
What is the current status of trial NCT02218190?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2014-08. Estimated completion is 2019-01.
What conditions does trial NCT02218190 study?
This clinical trial studies the following conditions: Spinal Fusion, Ileus.
What interventions are being tested in trial NCT02218190?
The interventions under investigation include: Placebo (DRUG), Alvimopan (DRUG).
Who is sponsoring clinical trial NCT02218190?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02218190 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02218190's enrollment target sits among peer trials
31 18th of 19 higher than 2 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulse-Width Modulation
RECRUITING · NA
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
-
Lumbar Fusion With Porous Versus Non-Porous Cages
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia